A multinational report to characterise SARS-CoV-2 infection in people with cystic fibrosis

A cluster of cases of pneumonia of unknown origin presented in Wuhan, China in early December 2019; the cause was subsequently found to be a novel coronavirus, now named SARS-Cov-2 [1]. This new virus is highly transmissible and has resulted in a pandemic with over 2 million confirmed infections and more than 145,000 deaths in humans in 185 countries [2].

Source: Journal of Cystic Fibrosis - May 2, 2020 Category: Respiratory Medicine Authors: Rebecca Cosgriff, Susannah Ahern, Scott C. Bell, Keith Brownlee, Pierre-R égis Burgel, Cass Byrnes, Harriet Corvol, Stephanie Y. Cheng, Alexander Elbert, Albert Faro, Christopher H. Goss, Vincent Gulmans, Bruce C. Marshall, Edward McKone, Peter G. Middle Source Type: research